Ingredion Incorporated Declares Quarterly Dividend of $0.78 per Share
May 15, 2024 16:07 ET
|
Ingredion Incorporated
WESTCHESTER, Ill., May 15, 2024 (GLOBE NEWSWIRE) -- Today, the board of directors of Ingredion Incorporated (NYSE: INGR) declared a quarterly dividend of $0.78 per share on the Company’s common...
Robinhood Markets, Inc. Reports April 2024 Operating Data
May 15, 2024 16:07 ET
|
Robinhood Markets, Inc.
MENLO PARK, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today reported select monthly operating data for April 2024: Funded Customers at the end of...
Envoy Medical Reports First Quarter 2024 Results
May 15, 2024 16:05 ET
|
Envoy Medical, Inc
The Company, a current leader in fully implanted hearing devices, continues to steadily march towards its ambition of disrupting the existing cochlear implant industry with its “breakthrough” fully...
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
May 15, 2024 16:05 ET
|
Spero Therapeutics, Inc.
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024Enrollment ongoing in PIVOT-PO, a...
Snail, Inc. Reports First Quarter 2024 Financial Results
May 15, 2024 16:05 ET
|
Snail, Inc.
CULVER CITY, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Snail, Inc. (NASDAQ: SNAL) (“Snail” or “the Company”), a leading, global independent developer and publisher of interactive digital...
TOMI Environmental Solutions, Inc. Reports First Quarter 2024 Financial Results
May 15, 2024 16:05 ET
|
TOMI Environmental Solutions, Inc.
FREDERICK, Md., May 15, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination utilizing its premier...
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
May 15, 2024 16:05 ET
|
Rezolute, Inc.
Patient enrollment underway in sunRIZE global Phase 3 clinical study of RZ358 in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Completed in-vivo toxicology...
FormFactor Again Named One of THE BEST Suppliers in the Semiconductor Industry
May 15, 2024 16:05 ET
|
FormFactor, Inc.
LIVERMORE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- FormFactor, Inc. (NASDAQ: FORM), a leading semiconductor test and measurement supplier, announced that it has again been named a top performer in...
Dave to Participate in the FT Partners Equity Research Weekly Forum on May 17th
May 15, 2024 16:05 ET
|
Dave Operating LLC
LOS ANGELES, May 15, 2024 (GLOBE NEWSWIRE) -- Dave Inc. (“Dave” or the “Company”) (Nasdaq: DAVE), one of the nation’s leading neobanks, today announced that the Company will participate in the...
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
May 15, 2024 16:05 ET
|
ReShape Lifesciences Inc
Commercial Launch of Next-Generation Lap-Band® 2.0 FLEX Continues Significant Reduction in Overall Operating Expenses of 51% in the First Quarter of 2024 Compared to the First Quarter of 2023 ...